German conglomerate Bayer on Wednesday said it will sell a new soybean product called Intacta 5+ for farmers in Brazil, the ...

Bayer's chief executive Bill Anderson looks set to keep his role until nearly the decade, as his turnaround plan for the group starts to deliver results. Just over two years into Anderson's tenure, ...

Bayer's much-anticipated stem cell therapy for Parkinson's disease is gathering momentum, with dosing in phase 3 trials now underway. The first patient has already been treated with bemdaneprocel, a ...

Wall Street's main indexes rose on Monday, on the back of gains from tech stocks and mega-caps such as Alphabet, as growing bets on a Federal Reserve rate cut in December fueled risk-taking. ago ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

At this year’s Trade Talk in Kansas City, Bayer unveiled Vyconic, a groundbreaking soybean variety aimed at improving farm ...

Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science ...